To assess the risks of non-sterility each organization should develop a Contamination control strategy. This requires an assessment, acknowledgement and remediation process for contamination risks. A contamination control strategy will be multifaceted and complex; as a means of addressing some of the basics and in raising some points for consideration, this article discusses the key starting points to be included in contamination control strategy for aseptically produced products.
In relation to this, Tim Sandle has written an article for American Pharmaceutical Review. The reference is:
To view the article, click here.
Posted by Dr. Tim Sandle
